East Rutherford, NJ – November 5, 2018 – Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), and finished dosage forms, today announced that third quarter 2018 financial results will be released on Thursday, November 8, 2018 before the market opens.
The Company will host a conference call to discuss the financial results.
|Third Quarter 2018 Earnings Conference Call|
|When:||Thursday, November 8, 2018 at 8:30 a.m. Eastern Time|
|Dial-in:||1-877-830-2649 for U.S.|
|+1-785-424-1824 for International|
|Dial-in Replay:||1-888-203-1112 for U.S.|
|+1-719-457-0820 for International|
|Available through Thursday, November 15, 2018|
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), finished dosage forms, advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and continuous processing. For more information, please visit www.cambrex.com
Investor Relations Associate